Michael G. Grey, Director of Mirum Pharmaceuticals MIRM, has filed 0 purchases and 7 sales on the open market. Over the past 12 months that comes to a net sale of $11.1M. The latest trade was on 06/15.

MG

MG

Michael G. Grey

Director

Company

Mirum Pharmaceuticals MIRM

First filing

23/05/02

Trades

63 trades

Buys / sales

0 / 7

12-month net buying

−$11.1M

Last trade

06/15

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Mirum PharmaceuticalsMIRM	Open-market sale10b5-1 plan	25/12/19	25/12/23	50,000 sh	$78.00	$3,900,000	−100.0%
Mirum PharmaceuticalsMIRM	Open-market sale10b5-1 plan	25/12/01	25/12/02	50,000 sh	$74.00	$3,700,000	−100.0%
Mirum PharmaceuticalsMIRM	Open-market sale10b5-1 plan	25/11/21	25/11/25	50,000 sh	$70.00	$3,500,000	−100.0%
Mirum PharmaceuticalsMIRM	Open-market sale	23/09/13–23/09/14	23/09/14	14,608 sh2 trades	$32.00avg.	$467,456	−100.0%
Mirum PharmaceuticalsMIRM	Open-market sale10b5-1 plan	23/06/08	23/06/09	14,608 sh	$29.00	$423,632	−100.0%
Mirum PharmaceuticalsMIRM	Open-market sale10b5-1 plan	23/05/03	23/05/04	14,608 sh	$28.00	$409,024	−100.0%